Hepatitis A virus (HAV) particles harbouring a physically defective RNA genome have been reported to occur in all HAV-infected cell culture systems analysed so far. The most prominent defects consist of three distinct overlapping deletions in the region of the HAV genome encoding the structural proteins. By probing for the endpoints of these deletions in RNA samples using S1 nuclease and exonuclease VII mapping, we obtained suggestive evidence for the existence also of defective genomes in HAV particles present in faecal specimens, in viraemic blood collected in the course of hepatitis A virus infection in man, as well as in the liver of an experimentally infected marmoset monkey. The deletions identified extend from nucleotide (nt) 1200 to nt 3820 and from nt 1200 to nt 3240 of the HAV genome. They are compatible with two of the deletions detected in particles grown in vitro in cell cultures and shown to interfere with the replication of standard hepatitis A virions.
In recent studies aimed at the factors operating in the establishment and maintenance of persistent hepatitis A virus (HAV) infection in cell culture, we obtained evidence for the widespread occurrence of HAV particles harbouring a physically defective RNA genome (Ntiesch et al., 1988) . The most prominent defects consisted of three distinct types of deletions spanning a considerable part of or the whole region encoding the viral structural proteins. Moreover, genomes with 3' proximal truncations of variable size were detected. Further experiments yielded suggestive evidence that such defective particles interfere with the replication of standard hepatitis A virions in susceptible cell cultures (J. P. F. Niiesch et al., unpublished results) . Thus, they show all properties of defective interfering (DI) particles.
DI particles have been detected in cell culture harvests of almost all viruses (for review, see Barrett & Dimmock, 1986) . Their ability to modulate replication of standard virus in vitro and in vivo, as well as their role in the establishment of persistent infection have been studied extensively in various experimental systems. However, there is not yet an unequivocal report on the isolation of DI virus from clinical specimens in the course of natural infection of man or animals. Our studies now provide evidence that the defective genomes previously identified in vitro in defective and evidently interfering HAV particles are also present in HAV particles in vivo.
Our analysis was based on consecutive faecal samples collected during the incubation period from patient MBB, who acquired the infection when crossing the Mediterranean Sea from North Africa to Italy (Fr6sner et al., 1979; Siegl et al., 1984) , also on faecal samples from two diseased individuals (KMW and CLF) in two separate outbreaks of hepatitis A in Switzerland (Schilt et al., 1982; Siegl et al., 1984) , on a sample of viraemic blood in a case of transfusionassociated hepatitis A (Hollinger et al. 1983) , as well as on extracts of the liver of a marmoset monkey experimentally infected with HAV derived from a sample of human stool (CR326) 7500 2900 1540 Fig. 1 . Northern blot analysis of HAV RNA extracted from particles in human faecal specimens (MBB 11/4, MBB 11/5, MBB 11/7, MBB 11/9, KMW 1 collected 6, 5, 3 and 1 day before, and 2 days after the onset of clinical disease, respectively) and in the liver of an experimentally infected marmoset monkey. Suspensions of the materials (10~) were centrifuged at 16500g at 4 °C for 15 min. The resulting supernatants were extracted twice with chloroform and digested with DNase (50 ktg/ml, at 37 °C for 2 h) and RNase (201xg/ml, at room temperature for 30 min). Particles were then pelleted by ultracentrifugation (100000g, 16h) and viral RNA was recovered after pretreatment with proteinase K (400 ~tg/ml, 0.1 M-Tris-HC1 pH 7.2, 1 ~ SDS, at 37 °C for 30 rain) by extraction with phenol :chloroform (1 : 1) and precipitation with ethanol. Northern blot transfers onto GeneScreen-Plus and hybridization were performed as described previously (Niiesch et al., 1988) . Numbers indicate nucleotides. collected in Costa Rica (Provost et al., 1975) . All these viruses were available as cell culture isolates and some of the isolates have been shown to contain defective HAV particles (Nfiesch et al., 1988) . Virus particles contained in the clinical samples were purified and viral R N A was extracted as described in the legend to Fig. 1 . As illustrated in this figure, Northern blotting of viral R N A revealed that the standard viral genome and the subgenomic viral R N A were present in all specimens. However, the quantity of both R N A species varied with the origin of the sample and, where consecutive specimens were available, with the time of infection.
The appearance of shorter than genome length R N A s could reflect either the presence of subgenomic viral R N A s in defective HAV particles or the breakdown of molecules during extraction; it could also be due to contamination With non-viral R N A molecules that crosshybridize with HAV c D N A probes. The latter possibility appears likely from results Of previous experiments (de Chastonay & Siegl, 1987) as well as from observations that c D N A of various picornaviral genomes detect eukaryotic r R N A even under stringent conditions of hybridization (McClure & Perrault, 1986) . To test for this, 18S and 28S r R N A from uninfected MRC-5 cells were electrophoretically separated. Multiple identical blots of this R N A were then hybridized separately to the 3Zp-labelled R N A transcripts of six regions of the cloned H A V genome (Fig. 2 ). They were used for hybridization in both the positive and the negative polarity. All positivestranded R N A probes failed to detect r R N A sequences. However, negative-stranded probes specific for the 5' untranslated region, the P2 region, and for the P3 region of the H A V genome, detected 28S r R N A to various degrees with sequences from the P3 region leading to the most pronounced reactions. No cross-hybridization could be recorded with probes spanning most of the HAV sequences specifying viral structural proteins.
In a second control experiment we added extracts of r R N A to faecal samples devoid of H A V particles and subjected this mixture tO the standard purification. Hybridization of Northern blots derived from such materials never gave a detectable signal on autoradiographs. Therefore, it can be assumed that the purification procedure effectively removes any non-encapsidated, non-viral R N A from the faecal extracts and it may be concluded that the signals observed in the experiments depicted in Fig. 1 are indeed specific for H A V RNA.
Finally, we tried to obtain direct proof for the presence of defective genomes in H A V particles purified from human faecal samples, from extracts of marmoset liver, as well as from viraemic . In (c), 2 ~tg samples of rRNA extracted from MRC-5 cells were electrophoresed and, after transfer to nitrocellulose, were hybridized to the negative-stranded HAV cRNA probes used for (b). Hybridization with positivestranded transcripts always gave negative results. None of the probes hybridized to 18S rRNA. Asterisk (*) denotes corrected intensity; pictured is an overexposed autoradiogram of a slot blot hybridization.
human plasma. For this purpose viral R N A was extracted as described ( Fig. 1 ) and subjected to S 1 nuclease and exonuclease VII mapping to probe for the endpoints of the three major deletions A to C previously reported to be present in H A V DI particles in cell cultures (NiJesch et al., 1988) . All attempts to obtain evidence for deletion A with termini at nucleotides (nO 930 and nt 4380 failed. For deletion B (reported to extend from nt 1140 to nt 3820) a 5'-terminal breakpoint at nt 1200 could be identified with some certainty by S 1 mapping of R N A samples originating from faecal samples of patients MBB and K M W . The existence of deletion B in the latter R N A was confirmed by mapping with exonuclease VII. According to comparative mapping experiments with DI R N A genomes cloned in cell cultures this breakpoint is identical with the 5' starting point of deletion B which was originally assigned to nt 1140. The discrepancy between the mapping data resulted evidently from the use of an inappropriate resolving gel system during the determination of this specific endpoint in previous studies. Examination of viral R N A from marmoset liver extracts for the presence of the 5'-terminal endpoint of deletion 3 . Mapping of the 3"-terminal breakpoint of deletion C within the capsid protein gene region. Viral RNA prepared from clinical specimens was hybridized to a cDNA probe labelled at the 5' end of the negative strand at the Avail site at position 3480. Hybrids were digested with S 1 nuclease and protected cDNA fragments were resolved on a sequencing gel. During digestion with S1 nuclease, protection by standard viral RNA yields a fragment of 440 nt, whereas partial protection by the defective genome of type C results in a smaller fragment of 240 nt. The corresponding deletion breakpoint is located at nt 3240. All other fragments shown in these S1 mapping experiments, and probably due to incomplete homology between viral RNA and labelled probe, were not confirmed by exonuclease VII mapping (data not shown). M, DNA size markers (pBR322/HpalI); X, position of label on the S1 hybridization probe.
B also yielded a characteristic yet rather faint band on the autoradiograph. Documentation of such bands on a photographic print proved to be extremely difficult, therefore they are not shown. However these and other faint bands could be reproduced regularly whenever the quantity of clinical material permitted repetitions of experiments. Similar results were obtained for the 3' terminus of deletion B at nt 3820 with R N A from samples 11/4, 11/5 and 11/9 of patient MBB. For R N A derived from MBB 11/5 the breakpoint at nt 3820 was confirmed by exonuclease VII digestion (data not shown). The search for the 5' end of deletion C (nt 1370 to nt 3240) with various c D N A probes yielded negative results with all viral samples. In contrast, the 3' terminus of this deletion could be identified readily in H A V particles contained in human stool, marmoset liver, and even human viraemic blood (Fig. 3) . The presence of only one identifiable 5'-terminal breakpoint together with two demonstrable 3'-terminal breakpoints suggests that the most prominent internal deletions in defective H A V particles in clinical specimens extend between nt 1200 and nt 3820 (deletion B) and between nt 1200 and nt 3240. , and from early passage of these HAV strains in cell culture (C). Viral RNA was prepared as described and hybridized to a cDNA probe labelled at the 5' end of the negative strand at the AvaII site at position 3480. Hybrids were digested with Sl nuclease and protected cDNA fragments were resolved on a sequencing gel. For further details see Fig. 3 .
isolated from clinical specimens and in particles produced after a few passages in vitro in cell cultures infected with such materials. However control experiments, in which two HAVnegative human stools were subjected to standard procedures for extraction and analysis, always yielded negative mapping results. We never obtained evidence for the presence of deletions other than B and C. In full agreement with previous findings (Nfiesch et al., 1988) , this underlines the predominance of some regions of the HAV genome for the formation of internal deletions. Whether or not Y-proximal truncations (Nfiesch et al., 1988) could also contribute to the size spectrum of subgenomic HAV R N A in vivo was not investigated owing to the lack of sufficient clinical material.
In conclusion, our data support the existence in vivo of defective HAV particles which, when present in cell cultures, are able to interfere with the replication of standard HAV. From experimental studies there is convincing evidence that comparable DI particles of various viruses can influence the course of acute infections. Apparently their presence, even in a barely detectable quantity, can ameliorate the effects of the replication of virulent virus, and favourably modulate the immune response of the host to virus infection, but also can facilitate the establishment of persistent infection (Barrett & Dimmock, 1986) . What then is the role of such particles in an HAV infection? Hepatitis A is a relatively benign, usually self-limiting disease with no tendency (or at least no well documented tendency) for the development of a persistent infection or chronic disease. Compared to the course of infections with better known members of the picornavirus family, the most conspicuous characteristics are the relatively extended incubation period of up to 36 days and the usually well developed immune response at the time that the infection becomes clinically manifest. As far as clinical materials and the sensitivity of experimental techniques permitted a detailed analysis, HAV DI particles are present both early and late during infection and in all specimens (liver, blood, faeces) known to yield infectious HAV at some point during infection. It remains to be shown to what extent (if any) this omnipresence of DI particles is related to the distinguishing features of HAV infection mentioned above.
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